AMGN compared with CGEM: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CGEMCullinan Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CGEMCullinan Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34▲+3.70%· post 480.00

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

CGEMCullinan Therapeutics, Inc.

12.48▼−20.76%· post 12.25

ClosedNov 4 '26

Mkt cap$803.8MRevenue—Revenue—

Compare

ClosedNov 4 '26

AMGNAmgen Inc

CGEMCullinan Therapeutics, Inc.

478.34▲+3.70%post 480.00

Price

12.48▼−20.76%post 12.25

$258.8B

Mkt cap

$803.8M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN478.34▲+3.70%vsCGEM12.48▼−20.76%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

AMGN, solidCGEM, dashed

Supply-chain overlap

Revenue flow

CGEM: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only CGEM 7

—Chongqing Genrix Biopharmaceuticalunlistedsupplier

—Harbour BioMed USunlistedsupplier

—Taiho Pharmaceuticalunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Deutsches Krebsforschungszentrumunlistedsupplier

3 more · CGEM chain ›